Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Hematological Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07714213
What this trial is testing

Post-acute Infectious Syndrome - Aripiprazole Symptom Evaluation (PAIS-AriSE)

Who this might be right for
Post-acute Infectious Syndrome (PAIS)Post-COVID-19 Condition (PCC or Long COVID)
Christiana Franke 138
Not applicableStudy completedNCT03485170
What this trial is testing

PET Imaging of Hemophilic Arthropathy

Who this might be right for
HemophiliaArthropathyInflammation
Tri-Service General Hospital (TSGH) 20
Not applicableStudy completedNCT00069680
What this trial is testing

Genetic Analysis of Gray Platelet Syndrome

Who this might be right for
Genetic LinkageMyelofibrosis
National Human Genome Research Institute (NHGRI) 123
Testing effectiveness (Phase 2)Looking for participantsNCT03128996
What this trial is testing

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

Who this might be right for
Severe Sickle Cell DiseaseBone Marrow Failure SyndromesMetabolic Disorders+3 more
Washington University School of Medicine 29
Not applicableStudy completedNCT03243812
What this trial is testing

Muscle Function and Its Biological and Physiological Determinants in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Hospices Civils de Lyon 77
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Early research (Phase 1)Study completedNCT00095472
What this trial is testing

Therapeutic Application of Intravascular Nitrite for Sickle Cell Disease

Who this might be right for
Sickle Cell Anemia
National Heart, Lung, and Blood Institute (NHLBI) 18
Not applicableStudy completedNCT02983253
What this trial is testing

Immunmodulation in Patients With HHT

Who this might be right for
Hereditary Haemorrhagic Telangiectasia (HHT)
University Hospital, Essen 124
Large-scale testing (Phase 3)Study completedNCT01454739
What this trial is testing

Long-Term Safety and Efficacy of rFVIIIFc in the Prevention and Treatment of Bleeding Episodes in Previously Treated Participants With Hemophilia A

Who this might be right for
Hemophilia A
Bioverativ Therapeutics Inc. 240
Not applicableStudy completedNCT01886261
What this trial is testing

Validation of Objective Measures of Place-Based Physical Activity

Who this might be right for
Physical Activity
University of California, San Diego 144
Not applicableWithdrawnNCT03401125
What this trial is testing

Risk Factors for Allo-immunization in Sickle Cell Disease

Who this might be right for
Sickle Cell Disease
Hanane EL KENZ
Large-scale testing (Phase 3)Study completedNCT01033747
What this trial is testing

Safety and Efficacy of Deferasirox in Patients With Transfusion Dependent Iron Overload - a Non-comparative Extension Study

Who this might be right for
Liver Iron Overload
Novartis Pharmaceuticals 70
Large-scale testing (Phase 3)Ended earlyNCT02433158
What this trial is testing

Safety of Rivipansel (GMI-1070) in the Treatment of One or More Vaso-Occlusive Crises in Hospitalized Subjects With Sickle Cell Disease

Who this might be right for
Sickle Cell AnemiaSickle Cell DiseaseSickle Cell Disorders+2 more
GlycoMimetics Incorporated 154
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07719348
What this trial is testing

Evaluate S241656 Alone or in Combination in Participants With Selected Myeloid Malignancies

Who this might be right for
Acute Myeloid LeukemiaChronic Myelomonocytic LeukemiaMyelodysplastic Syndrome Acute Myeloid Leukemia
Servier 64
Very early researchStudy completedNCT01822015
What this trial is testing

Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Monoblastic Leukemia (M5a)Adult Acute Monocytic Leukemia (M5b)+11 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 55
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Study completedNCT01917708
What this trial is testing

Bone Marrow Transplant With Abatacept for Non-Malignant Diseases

Who this might be right for
Hurler SyndromeFanconi AnemiaGlanzmann Thrombasthenia+12 more
Emory University 10
Not applicableAvailableNCT03720626
What this trial is testing

Managed Access Programs for SEG101, Crizanlizumab

Who this might be right for
Sickle Cell Disease
Novartis Pharmaceuticals
Not applicableLooking for participantsNCT00230685
What this trial is testing

Case Notes Review on Patients With Hereditary Haemorrhagic Telangiectasia

Who this might be right for
Telangiectasia, Hereditary Hemorrhagic
Imperial College London 2,000
Testing effectiveness (Phase 2)UnknownNCT00408447
What this trial is testing

Stem Cell Transplant in Sickle Cell Disease and Thalassemia

Who this might be right for
Sickle Cell DiseaseBeta Thalassemia
Columbia University 53
Next Page